Development Licenses. On a Lead Antibody, EDC Antibody, Licensed Antibody and Licensed TAP Antibody basis, Aventis hereby grants to ImmunoGen and its Affiliates a non-exclusive, non-sublicensable, royalty-free license, under the Aventis Intellectual Property and the Program Intellectual Property, to Develop Products in the manner and to the extent such Development is assigned to ImmunoGen by the Joint Development Committee.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Immunogen Inc), Collaboration and License Agreement (Immunogen Inc)
Development Licenses. On a Lead Antibody, EDC Antibody, Licensed Antibody and Licensed TAP Antibody basis, Aventis ImmunoGen hereby grants to Aventis and its Affiliates, subject to Section 7.1.8 below, an exclusive (even as to ImmunoGen and its Affiliates a non-exclusiveAffiliates), non-sublicensableworldwide, royalty-free license, with the right to grant sublicenses to Approved Subcontractors, under the Aventis Intellectual Property and the Program ImmunoGen Intellectual Property, to Develop Products in the manner and to the extent such Development is assigned to ImmunoGen by the Joint Development CommitteeProducts.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Immunogen Inc), Collaboration and License Agreement (Immunogen Inc)